[{"address1": "9704 Medical Center Drive", "city": "Rockville", "state": "MD", "zip": "20850", "country": "United States", "phone": "301 251 5172", "fax": "301 251 5321", "website": "https://www.macrogenics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.", "fullTimeEmployees": 341, "companyOfficers": [{"maxAge": 1, "name": "Mr. James  Karrels", "age": 57, "title": "Senior VP, CFO & Corporate Secretary", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 663431, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen L. Eck M.D., Ph.D.", "age": 69, "title": "Senior VP of Clinical Development & Chief Medical Officer", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 735308, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric Blasius Risser", "age": 51, "title": "CEO, President & Director", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 651362, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thomas M. Spitznagel Ph.D.", "age": 57, "title": "Senior Vice President of Technical Operations", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 550974, "exercisedValue": 204497, "unexercisedValue": 490417}, {"maxAge": 1, "name": "Dr. Ezio  Bonvini M.D.", "age": 70, "title": "Senior VP of Research & Chief Scientific Officer", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 612208, "exercisedValue": 264031, "unexercisedValue": 199063}, {"maxAge": 1, "name": "Mr. Jeffrey Stuart Peters J.D.", "age": 53, "title": "Senior VP, General Counsel & Corporate Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steve  Harig", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harish  Krishnaswamy", "title": "Senior Vice President of Business Development & Portfolio Planning", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth  Smith", "age": 56, "title": "VP, Controller & Treasurer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.71, "open": 1.72, "dayLow": 1.71, "dayHigh": 1.83, "regularMarketPreviousClose": 1.71, "regularMarketOpen": 1.72, "regularMarketDayLow": 1.71, "regularMarketDayHigh": 1.83, "payoutRatio": 0.0, "beta": 1.61, "forwardPE": -0.73858917, "volume": 722989, "regularMarketVolume": 722989, "averageVolume": 755701, "averageVolume10days": 519590, "averageDailyVolume10Day": 519590, "bid": 1.75, "ask": 1.79, "bidSize": 6, "askSize": 6, "marketCap": 112506152, "fiftyTwoWeekLow": 0.99, "fiftyTwoWeekHigh": 5.1, "allTimeHigh": 41.0, "allTimeLow": 0.99, "priceToSalesTrailing12Months": 0.679816, "fiftyDayAverage": 1.6572, "twoHundredDayAverage": 1.95515, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 43527152, "profitMargins": -0.21993999, "floatShares": 52560599, "sharesOutstanding": 63205703, "sharesShort": 3730266, "sharesShortPriorMonth": 3898750, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.059, "heldPercentInsiders": 0.032509997, "heldPercentInstitutions": 0.76593, "shortRatio": 3.89, "shortPercentOfFloat": 0.0726, "impliedSharesOutstanding": 64321098, "bookValue": 0.738, "priceToBook": 2.4119241, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -36399000, "trailingEps": -0.57, "forwardEps": -2.41, "enterpriseToRevenue": 0.263, "enterpriseToEbitda": -0.618, "52WeekChange": -0.5041783, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 1.78, "targetHighPrice": 5.0, "targetLowPrice": 3.0, "targetMeanPrice": 3.75, "targetMedianPrice": 3.5, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 176486000, "totalCashPerShare": 2.792, "ebitda": -70462000, "totalDebt": 107507000, "quickRatio": 4.847, "currentRatio": 5.255, "totalRevenue": 165495008, "debtToEquity": 230.613, "revenuePerShare": 2.631, "returnOnAssets": -0.21841998, "returnOnEquity": -0.69705003, "grossProfits": -16094000, "freeCashflow": -50392248, "operatingCashflow": -72120000, "revenueGrowth": 1.06, "grossMargins": -0.09725001, "ebitdaMargins": -0.42576998, "operatingMargins": -1.65271, "financialCurrency": "USD", "symbol": "MGNX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 4.09356, "regularMarketPrice": 1.78, "shortName": "MacroGenics, Inc.", "exchange": "NMS", "messageBoardId": "finmb_600911", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1759533549, "regularMarketTime": 1759521601, "longName": "MacroGenics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1381411800000, "postMarketChangePercent": -0.561797, "postMarketPrice": 1.77, "postMarketChange": -0.00999999, "regularMarketChange": 0.0699999, "regularMarketDayRange": "1.71 - 1.83", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 755701, "marketState": "CLOSED", "fiftyTwoWeekLowChange": 0.78999996, "fiftyTwoWeekLowChangePercent": 0.7979798, "fiftyTwoWeekRange": "0.99 - 5.1", "fiftyTwoWeekHighChange": -3.32, "fiftyTwoWeekHighChangePercent": -0.6509804, "fiftyTwoWeekChangePercent": -50.417828, "earningsTimestampStart": 1762286400, "earningsTimestampEnd": 1762286400, "earningsCallTimestampStart": 1742502600, "earningsCallTimestampEnd": 1742502600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.57, "epsForward": -2.41, "epsCurrentYear": -1.71, "priceEpsCurrentYear": -1.0409356, "fiftyDayAverageChange": 0.12279999, "fiftyDayAverageChangePercent": 0.07410089, "twoHundredDayAverageChange": -0.17515004, "twoHundredDayAverageChangePercent": -0.08958394, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.5 - Buy", "cryptoTradeable": false, "displayName": "MacroGenics", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]